google-site-verification: googlec7193c3de77668c9.html

Developing a human hepatocyte model with enhanced drug-metabolizing enzyme activity

[
A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty of Pharmaceutical Sciences at Toho University, have developed a new HepaRG cell line with markedly enhanced activity of CYP2D6, a major drug-metabolizing enzyme. This engineered human hepatocyte model enables more human-relevant evaluation of drug-induced hepatotoxicity mediated by CYP2D6. The study was published in the journal PLOS ONE on December 29, 2025.


Source link

Advertisements

See also  'Adenomyosis ruined my life'

Check Also

3D printing method could expand options for personalized cardiovascular devices

[ 3D-printed nitinol tapered flow-diverter stent with variable fiber density, sectional size and shape. Credit: …

I have a condition people are too embarrassed to talk about

The lifelong inflammatory condition affects genitals and can cause white patches to form with itching, …

AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment

[ Researchers are using AI tools to analyze simple facial photographs to determine key indicators …

Leave a Reply

Available for Amazon Prime